A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research.
paper
Cited
Public
- Authors
- De Jager, Philip L; Ma, Yiyi; McCabe, Cristin; Xu, Jishu; Vardarajan, Badri N; Felsky, Daniel; Klein, Hans-Ulrich; White, Charles C; Peters, Mette A; Lodgson, Ben; Nejad, Parham; Tang, Anna; Mangravite, Lara M; Yu, Lei; Gaiteri, Chris; Mostafavi, Sara; Schneider, Julie A; Bennett, David A
- Year
- 2018
- Journal
- Scientific data
- PMID
- 30084846
- DOI
- 10.1038/sdata.2018.142
- PMCID
- PMC6080491
We initiated the systematic profiling of the dorsolateral prefrontal cortex obtained from a subset of autopsied individuals enrolled in the Religious Orders Study (ROS) or the Rush Memory and Aging Project (MAP), which are jointly designed prospective studies of aging and dementia with detailed, longitudinal cognitive phenotyping during life and a quantitative, structured neuropathologic examination after death. They include over 3,322 subjects. Here, we outline the first generation of data including genome-wide genotypes (n=2,090), whole genome sequencing (n=1,179), DNA methylation (n=740), chromatin immunoprecipitation with sequencing using an anti-Histone 3 Lysine 9 acetylation (H3K9Ac) antibody (n=712), RNA sequencing (n=638), and miRNA profile (n=702). Generation of other omic data including ATACseq, proteomic and metabolomics profiles is ongoing. Thanks to its prospective design and recruitment of older, non-demented individuals, these data can be repurposed to investigate a large number of syndromic and quantitative neuroscience phenotypes. The many subjects that are cognitively non-impaired at death also offer insights into the biology of the human brain in older non-impaired individuals.
Overlap of the different layers of βomicβ data.The venn diagram illustrates the extent to which the different layers of overlap in the ROS and MAP subjects that have been processed to date. 458 subjects have all layers of data described in this report.
Overlaps between pathologic and clinical diagnosis of Alzheimerβs dementia in ROSMAP.We illustrate the distribution of clinical diagnoses found in the ROSMAP subjects that meet a pathologic diagnosis of AD and in those that do not. We used the NIA-REAGAN guidelines for a pathologic diagnosis of AD, and all subjects were diagnosed as either having AD (AD_REGAN=1) or not (AD_RAEGAN=0). The clinical diagnosis of Alzheimerβs dementia was performed based on a review of all available clinical data by neurologists with expertise in dementia. Participants not fulfilling diagnostic criteria for AD dementia were classified as having mild cognitive impairment, being cognitively non-impaired, and having another form of dementia.
1β20 of 46
Next β
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AdzhubeiI., JordanD. M. & SunyaevS. R. Predicting functional effect of human missense mutations using PolyPhen-2. Current protocols in human genetics / editorial board, Jonathan L. Haines... [et al] Chapter 7(Unit7): 20 (2013).10.1002/0471142905.hg0720s76PMC448063023315928 | β | β | β |
| Alcala-LozanoR. et al. Similar clinical improvement and maintenance after rTMS at 5 Hz using a simple vs. complex protocol in Alzheimer's disease. Brain Stimul 8, 625β627 (2017).10.1016/j.brs.2017.12.01129326021 | β | β | β |
| AllenG. I. et al. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. Alzheimers Dement 12, 645β653 (2016).2707975310.1016/j.jalz.2016.02.006PMC5474755 | β | β | β |
| AlmeidaA. L. et al. Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer. Acta Cir Bras 31(Suppl 1): 13β18 (2016).2714289910.1590/S0102-86502016001300004 | β | β | β |
| BennettD. A. et al. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res 9, 646β663 (2012).2247186710.2174/156720512801322663PMC3439198 | β | β | β |
| BennettD. A., SchneiderJ. A., ArvanitakisZ. & WilsonR. S. Overview and findings from the religious orders study. Curr Alzheimer Res 9, 628β645 (2012).2247186010.2174/156720512801322573PMC3409291 | β | β | β |
| BraakH., ThalD. R., GhebremedhinE. & Del TrediciK. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70, 960β969 (2011).2200242210.1097/NEN.0b013e318232a379 | β | β | β |
| ChenY. A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203β209 (2013).2331469810.4161/epi.23470PMC3592906 | β | β | β |
| CooperG. M. et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome research 15, 901β913 (2005).1596502710.1101/gr.3577405PMC1172034 | β | β | β |
| De JagerP. L. et al. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging 33, 1017 e1011βe1015 (2012).10.1016/j.neurobiolaging.2011.09.033PMC330789822054870 | β | β | β |
| De JagerP. L. et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17, 1156β1163 (2014).2512907510.1038/nn.3786PMC4292795 | β | β | β |
| DePristoM. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43, 491β498 (2011).2147888910.1038/ng.806PMC3083463 | β | β | β |
| FanM. et al. Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults. Neurosci Lett 479, 332β336 (2010).2057357410.1016/j.neulet.2010.05.092PMC2954463 | β | β | β |
| GeQ. et al. miRNA in plasma exosome is stable under different storage conditions. Molecules 19, 1568β1575 (2014).2447321310.3390/molecules19021568PMC6271968 | β | β | β |
| GlynnC. L., KhanS., KerinM. J. & DwyerR. M. Isolation of secreted microRNAs (miRNAs) from cell-conditioned media. Microrna 2, 14β19 (2013).2507071110.2174/2211536611302010003 | β | β | β |
| GuintivanoJ., AryeeM. J. & KaminskyZ. A. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics 8, 290β302 (2013).2342626710.4161/epi.23924PMC3669121 | β | β | β |
| GuoX. M., LiuH. & QianJ. Daily iron supplementation on cognitive performance in primary-school-aged children with and without anemia: a meta-analysis. International journal of clinical and experimental medicine 8, 16107β16111 (2015).26629120PMC4659009 | β | β | β |
| HibarD. P. et al. Novel genetic loci associated with hippocampal volume. Nat Commun 8, 13624 (2017).2809816210.1038/ncomms13624PMC5253632 | β | β | β |
| HirdM. A., EgetoP., FischerC. E., NaglieG. & SchweizerT. A. A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment. Journal of Alzheimer's disease: JAD 53, 713β729 (2016).2717607610.3233/JAD-160276 | β | β | β |
| JohnsonW. E., LiC. & RabinovicA. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118β127 (2007).1663251510.1093/biostatistics/kxj037 | β | β | β |
| KacperskaM. J. et al. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study. J Mol Neurosci 56, 154β163 (2015).2548731510.1007/s12031-014-0476-3PMC4382531 | β | β | β |
| KaplanJ. T., GimbelS. I. & HarrisS. Neural correlates of maintaining one's political beliefs in the face of counterevidence. Sci Rep 6, 39589 (2016).2800896510.1038/srep39589PMC5180221 | β | β | β |
| KumarP., HenikoffS. & NgP. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature protocols 4, 1073β1081 (2009).1956159010.1038/nprot.2009.86 | β | β | β |
| LevinJ. Z. et al. Comprehensive comparative analysis of strand-specific RNA sequencing methods. Nature methods 7, 709β715 (2010).2071119510.1038/nmeth.1491PMC3005310 | β | β | β |
| LiB. & DeweyC. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).2181604010.1186/1471-2105-12-323PMC3163565 | β | β | β |
| LiH. & DurbinR. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754β1760 (2009).1945116810.1093/bioinformatics/btp324PMC2705234 | β | β | β |
| LimA. S. et al. Diurnal and seasonal molecular rhythms in human neocortex and their relation to Alzheimer's disease. Nat Commun 8, 14931 (2017).2836800410.1038/ncomms14931PMC5382268 | β | β | β |
| MaH. R. et al. Aberrant pattern of regional cerebral blood flow in Alzheimer's disease: a voxel-wise meta-analysis of arterial spin labeling MR imaging studies. Oncotarget 8, 93196β93208 (2017).2919098910.18632/oncotarget.21475PMC5696255 | β | β | β |
| MatteiniA. M. et al. GWAS analysis of handgrip and lower body strength in older adults in the CHARGE consortium. Aging Cell 15, 792β800 (2016).2732535310.1111/acel.12468PMC5013019 | β | β | β |
| McKennaA. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome research 20, 1297β1303 (2010).2064419910.1101/gr.107524.110PMC2928508 | β | β | β |
| McKusickV. A. Mendelian Inheritance in Man and its online version, OMIM. Am J Hum Genet 80, 588β604 (2007).1735706710.1086/514346PMC1852721 | β | β | β |
| NewellK. L., HymanB. T., GrowdonJ. H. & Hedley-WhyteE. T. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. Journal of neuropathology and experimental neurology 58, 1147β1155 (1999).1056065710.1097/00005072-199911000-00004 | β | β | β |
| PriceA. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nature genetics 38, 904β909 (2006).1686216110.1038/ng1847 | β | β | β |
| PurcellS. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559β575 (2007).1770190110.1086/519795PMC1950838 | β | β | β |
| RagusaM et al. MicroRNAs in vitreus humor from patients with ocular diseases. Mol Vis 19, 430β440 (2013).23441115PMC3580974 | β | β | β |
| SchneiderJ. A., ArvanitakisZ., BangW. & BennettD. A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197β2204 (2007).1756801310.1212/01.wnl.0000271090.28148.24 | β | β | β |
| ShulmanJ. M. et al. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol 70, 1150β1157 (2013).2383640410.1001/jamaneurol.2013.2815PMC3773291 | β | β | β |
| SiepelA. et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome research 15, 1034β1050 (2005).1602481910.1101/gr.3715005PMC1182216 | β | β | β |
| SimsR. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49, 1373β1384 (2017).2871497610.1038/ng.3916PMC5669039 | β | β | β |
| StensonP. D. et al. Human Gene Mutation Database (HGMD): 2003 update. Human mutation 21, 577β581 (2003).1275470210.1002/humu.10212 | β | β | β |
| Synapse2016https://dx.doi.org/10.7303/syn2580853 | β | β | β |
| Synapse2016https://dx.doi.org/10.7303/syn3157322 | β | β | β |
| Synapse2016https://dx.doi.org/10.7303/syn3157325 | β | β | β |
| Synapse2016https://dx.doi.org/10.7303/syn3157329 | β | β | β |
| Synapse2016https://dx.doi.org/10.7303/syn3219045 | β | β | β |
| Synapse2016https://dx.doi.org/10.7303/syn3387325 | β | β | β |
| Synapse2016https://dx.doi.org/10.7303/syn3388564 | β | β | β |
| Synapse2016https://dx.doi.org/10.7303/syn4896408 | β | β | β |
| Synapse2017https://dx.doi.org/10.7303/syn10901595 | β | β | β |
| Synapse2017https://dx.doi.org/10.7303/syn3157275 | β | β | β |
| TrapnellC. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7, 562β578 (2012).2238303610.1038/nprot.2012.016PMC3334321 | β | β | β |
| WangK., LiM. & HakonarsonH. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic acids research 38, e164 (2010).2060168510.1093/nar/gkq603PMC2938201 | β | β | β |
| WassermanJ. K. & SchlichterL. C. White matter injury in young and aged rats after intracerebral hemorrhage. Exp Neurol 214, 266β275 (2008).1884893410.1016/j.expneurol.2008.08.010 | β | β | β |
| WhiteC. C. et al. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med 14, e1002287 (2017).2844142610.1371/journal.pmed.1002287PMC5404753 | β | β | β |
| YangJ. et al. Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies. Int J Biochem Cell Biol 67, 58β64 (2015).2600374010.1016/j.biocel.2015.05.009PMC4564337 | β | β | β |
| YuJ. et al. miR-202 expression concentration and its clinical significance in the serum of multiple myeloma patients. Ann Clin Biochem 51, 543β549 (2014).2404872110.1177/0004563213501155 | β | β | β |
| YuL. et al. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology 29, 335β343 (2015).2549583210.1037/neu0000159PMC4420708 | β | β | β |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases. | 2021 | 34417470 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A transcriptional program associated with neurotransmission in the living human brain. | Charney AW et al. | β | 2026 | β |
| Biological age acceleration associates with Alzheimer's disease plasma biomarker levels. | Eissman JM et al. | β | 2026 | β |
| Cross-ancestry information transfer framework improves protein abundance prediction and protein-trait association identification. | Zhai W et al. | β | 2026 | β |
| Deep-learning prediction of gene expression from personal genomes. | Drusinsky S et al. | β | 2026 | β |
| Genetic control of non-coding RNAs in the human brain and their implications for complex traits. | Chen L et al. | β | 2026 | β |
| Genetic predisposition to hand grip strength predicts cognitive decline. | Bercovitch R et al. | β | 2026 | β |
| HEXIM1/P-TEFb complex controls RNA polymerase II pause release and immediate early gene induction following neuronal depolarization. | Htet M et al. | β | 2026 | β |
| Integrative epigenomic landscape of Alzheimer's Disease brains reveals oligodendrocyte molecular perturbations associated with tau. | Oatman SR et al. | β | 2026 | β |
| Interactive effects of telomere length and genetic variants on Alzheimer disease risk across multiple ancestral populations. | Khurshid Z et al. | β | 2026 | β |
| RBFOX1 association with age at onset of Alzheimer's disease. | Xicota L et al. | β | 2026 | β |
| scTWAS: a powerful statistical framework for single-cell transcriptome-wide association studies. | Lin Z et al. | β | 2026 | β |
| Somatic cancer variants enriched in Alzheimer's disease microglia-like cells drive inflammatory and proliferative states. | Huang AY et al. | β | 2026 | β |
| Systems genetic dissection of brain gene expression reveals excitotoxic mechanisms of Alzheimer's disease. | Zhao P et al. | β | 2026 | β |
| The China Brain Multi-omics Atlas Project (CBMAP). | Zhou D et al. | β | 2026 | β |
| Accelerating biomedical discoveries in brain health through transformative neuropathology of aging and neurodegeneration. | Murray ME et al. | β | 2025 | β |
| Alzheimer's disease multi-ancestry genome-wide interaction and stratified study with smoking. | Dacey R et al. | β | 2025 | β |
| Alzheimer's disease transcriptional landscape in ex vivo human microglia. | Kosoy R et al. | β | 2025 | β |
| An analysis of RNA quality metrics in human brain tissue. | Tian J et al. | β | 2025 | β |
| An augmented GSNMF model for complete deconvolution of bulk RNA-seq data. | Li S et al. | β | 2025 | β |
| A personalized metabolic modelling approach through integrated analysis of RNA-Seq-based genomic variants and gene expression levels in Alzheimer's disease. | Uzuner Odongo D et al. | β | 2025 | β |
| Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions. | Ren F et al. | β | 2025 | β |
| Benchmark of cellular deconvolution methods using a multi-assay dataset from postmortem human prefrontal cortex. | Huuki-Myers LA et al. | β | 2025 | β |
| Brain 5-hydroxymethylcytosine alterations are associated with Alzheimer's disease neuropathology. | Zhao J et al. | β | 2025 | β |
| Cell type-specific inference from bulk RNA-sequencing data by integrating single-cell reference profiles via EPIC-unmix. | Tang C et al. | β | 2025 | β |
| Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD. | Wang S et al. | β | 2025 | β |
| CLU alleviates Alzheimer's disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density. | Lish AM et al. | β | 2025 | β |
| Combined single-cell profiling of chromatin-transcriptome and splicing across brain cell types, regions and disease state. | Hu W et al. | β | 2025 | β |
| Contributions of Genetic Variation in Astrocytes to Cell and Molecular Mechanisms of Risk and Resilience to Late-Onset Alzheimer's Disease. | Lee H et al. | β | 2025 | β |
| Cross-cohort genetic risk prediction for Alzheimer's disease: a transfer learning approach using GWAS and deep learning models. | Ihianle IK et al. | β | 2025 | β |
| Cyclooxygenase-1 deletion in 5βΓβFAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment. | Wang J et al. | β | 2025 | β |
| DEG-BRIN-GCN: interpretable graph convolutional framework with differentially expressed genes brain region interaction network prior for AD diagnosis. | Zhang Z et al. | β | 2025 | β |
| Differential Transcriptional Programs Reveal Modular Network Rearrangements Associated with Late-Onset Alzheimer's Disease. | PΓ©rez-GonzΓ‘lez AP et al. | β | 2025 | β |
| Discovery of Proteoforms Associated With Alzheimer's Disease Through Quantitative Top-Down Proteomics. | Fulcher JM et al. | β | 2025 | β |
| Early proteasome downregulation and dysfunction drive proteostasis failure in Alzheimer's disease. | Jiang S et al. | β | 2025 | β |
| Epigenetic dysregulation of transposable elements in cognitive impairment and Alzheimer's disease. | Cavalier AN et al. | β | 2025 | β |
| Genetic Markers of Postmortem Brain Iron. | Cornelis MC et al. | β | 2025 | β |
| Genetic variants associated with age-related episodic memory decline implicate distinct memory pathologies. | Ali A et al. | β | 2025 | β |
| Genome-wide pleiotropy analysis of longitudinal blood pressure and harmonized cognitive performance measures. | Kang M et al. | β | 2025 | β |
| Genotyping TOMM40'523 poly-T polymorphisms using whole-genome sequencing. | Vialle RA et al. | β | 2025 | β |
| Glymphatic system clearance and Alzheimer's disease risk: a CSF proteome-wide study. | Cullell N et al. | β | 2025 | β |
| Insights From a Scoping Review and Bibliometric Analysis of Trends and Advances in Biomarker Research: The Role of MicroRNAs in Cognitive Decline Across Neurodegenerative Diseases. | Reyes-Long S et al. | β | 2025 | β |
| Integrated Multi-Omics Analysis and Cross-Model Validation Reveal Mitochondrial Signatures in Alzheimer's Disease. | Xu X et al. | β | 2025 | β |
| Integrating brain proteomes and genetics to identify novel risk genes in chronic widespread musculoskeletal pain. | Dai Z et al. | β | 2025 | β |
| Integrating explainable artificial intelligence with multiomics systems biology and electronic health record data mining for personalized drug repurposing in Alzheimer's disease. | Mottaqi M et al. | β | 2025 | β |
| Integrating rare pathogenic variant prioritization with gene-based association analysis to identify novel genes and relevant multimodal traits for Alzheimer's disease. | Cao J et al. | β | 2025 | β |
| Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's disease. | Naderi Yeganeh P et al. | β | 2025 | β |
| Interaction of genetic variants and methylation in transcript-level expression regulation in Alzheimer's disease by multi-omics data analysis. | Han S et al. | β | 2025 | β |
| Interpretable modality-specific and interactive graph convolutional network on brain functional and structural connectomes. | Xia J et al. | β | 2025 | β |
| Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differences. | Shwab EK et al. | β | 2025 | β |
| Local genetic covariance analysis with lipid traits identifies novel loci for early-onset Alzheimer's Disease. | Ray NR et al. | β | 2025 | β |
| Lower expression of <i>BIN1's</i> neuronal isoform in vulnerable excitatory neurons increases risk in Alzheimer's disease. | Ranganathan R et al. | β | 2025 | β |
| Mapping medically relevant RNA isoform diversity in the aged human frontal cortex with deep long-read RNA-seq. | Aguzzoli Heberle B et al. | β | 2025 | β |
| Mapping the microRNA landscape in the older adult brain and its genetic contribution to neuropsychiatric conditions. | Vattathil SM et al. | β | 2025 | β |
| Microglial States Are Susceptible to Senescence and Cholesterol Dysregulation in Alzheimer's Disease. | Li B et al. | β | 2025 | β |
| Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheimer's disease. | Castanho I et al. | β | 2025 | β |
| Molecular signatures of regional vulnerability to tauopathy in excitatory cortical neurons. | Broekaart DWM et al. | β | 2025 | β |
| Multiancestry brain pQTL fine-mapping and integration with genome-wide association studies of 21 neurologic and psychiatric conditions. | Wingo AP et al. | β | 2025 | β |
| Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects. | Δ°Ε Γ et al. | β | 2025 | β |
| P2RX7 modulates the function of human microglia-like cells and mediates the association of IL18 with Alzheimer's disease traits. | Heavener KS et al. | β | 2025 | β |
| Perimenopausal state oestradiol to progesterone imbalance drives Alzheimer's risk via ERRΞ± dysregulation and energy dyshomeostasis. | Sun JK et al. | β | 2025 | β |
| Population-scale cross-disorder atlas of the human prefrontal cortex at single-cell resolution. | Fullard JF et al. | β | 2025 | β |
| Sex-specific associations of gene expression with Alzheimer's disease neuropathology and ante-mortem cognitive performance. | Seto M et al. | β | 2025 | β |
| Structural variants linked to Alzheimer's disease and other common age-related clinical and neuropathologic traits. | Vialle RA et al. | β | 2025 | β |
| Synaptic sabotage: How Tau and Ξ±-Synuclein undermine synaptic health. | Uytterhoeven V et al. | β | 2025 | β |
| Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue. | Aguzzoli Heberle B et al. | β | 2025 | β |
| Transcriptional regulation by PHGDH drives amyloid pathology in Alzheimer's disease. | Chen J et al. | β | 2025 | β |
| Transcriptomic analysis reveals suppression of steroidogenic acute regulatory protein in gender-specific differences in Alzheimer's disease. | Manna PR et al. | β | 2025 | β |
| Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes. | Mei Z et al. | β | 2025 | β |
| Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease. | Ren Y et al. | β | 2025 | β |
| ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling. | Tayran H et al. | β | 2024 | β |
| A benchmark of RNA-seq data normalization methods for transcriptome mapping on human genome-scale metabolic networks. | LΓΌleci HB et al. | β | 2024 | β |
| A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5. | Mahzarnia A et al. | β | 2024 | β |
| Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research. | Noori A et al. | β | 2024 | β |
| Analysis of the aging-related biomarker in a nonhuman primate model using multilayer omics. | Liu Y et al. | β | 2024 | β |
| APOE2 protects against AΞ² pathology by improving neuronal mitochondrial function through ERRΞ± signaling. | Ning Z et al. | β | 2024 | β |
| APOE genotype-specific methylation patterns are linked to Alzheimer disease pathology and estrogen response. | Panitch R et al. | β | 2024 | β |
| Association of whole-person eigen-polygenic risk scores with Alzheimer's disease. | Kharaghani A et al. | β | 2024 | β |
| A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model. | Latif-Hernandez A et al. | β | 2024 | β |
| Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia. | Guo S et al. | β | 2024 | β |
| Bridging the gap: Multi-omics profiling of brain tissue in Alzheimer's disease and older controls in multi-ethnic populations. | Reddy JS et al. | β | 2024 | β |
| CD33 and SHP-1/<i>PTPN6</i> Interaction in Alzheimer's Disease. | Beckers L et al. | β | 2024 | β |
| Cell subtype-specific effects of genetic variation in the Alzheimer's disease brain. | Fujita M et al. | β | 2024 | β |
| Cell-type-specific effects of age and sex on human cortical neurons. | Chien JF et al. | β | 2024 | β |
| CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer's disease. | Rybnicek J et al. | β | 2024 | β |
| Cognition-associated long noncoding RNAs are dysregulated upon severe COVID-19. | Lee JD et al. | β | 2024 | β |
| Critical reasoning on the co-expression module QTL in the dorsolateral prefrontal cortex. | Cote AC et al. | β | 2024 | β |
| CWAS-Plus: estimating category-wide association of rare noncoding variation from whole-genome sequencing data with cell-type-specific functional data. | Kim Y et al. | β | 2024 | β |
| CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET. | Nho K et al. | β | 2024 | β |
| Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model. | Martin Flores N et al. | β | 2024 | β |
| Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer's disease. | Nagaraj S et al. | β | 2024 | β |
| Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups. | Ma Y et al. | β | 2024 | β |
| Evaluating performance and applications of sample-wise cell deconvolution methods on human brain transcriptomic data. | Dai R et al. | β | 2024 | β |
| Genome-wide re-sequencing reveals regulatory genes and variants involved in the regulation of intermittent fertilization intensity in Wenchang chickens. | Wang X et al. | β | 2024 | β |
| GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia. | Shade LMP et al. | β | 2024 | β |
| Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease. | Chen Q et al. | β | 2024 | β |
| Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics. | Wu C et al. | β | 2024 | β |
| Integration across biophysical scales identifies molecular and cellular correlates of person-to-person variability in human brain connectivity. | Ng B et al. | β | 2024 | β |
| Integration of genomic and transcriptomic layers in RNA-Seq data leads to protein interaction modules with improved Alzheimer's disease associations. | DΓΌz E et al. | β | 2024 | β |
| In vivo validation of late-onset Alzheimer's disease genetic risk factors. | Sasner M et al. | β | 2024 | β |
| Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease. | Gammie SC et al. | β | 2024 | β |
| miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease. | Han SW et al. | β | 2024 | β |
| miR-133b as a potential regulator of a synaptic NPTX2 protein in Alzheimer's disease. | Han SW et al. | β | 2024 | β |
| mosGraphGen: a novel tool to generate multi-omics signaling graphs to facilitate integrative and interpretable graph AI model development. | Zhang H et al. | β | 2024 | β |
| Multi-fusion strategy network-guided cancer subtypes discovering based on multi-omics data. | Liu J et al. | β | 2024 | β |
| Multilayer Analysis of RNA Sequencing Data in Alzheimer's Disease to Unravel Molecular Mysteries. | Uzuner D et al. | β | 2024 | β |
| Multimodal analysis of RNA sequencing data powers discovery of complex trait genetics. | Munro D et al. | β | 2024 | β |
| Multi-omics analyses highlight molecular differences between clinical and neuropathological diagnoses in Alzheimer's disease. | LΓΌleci HB et al. | β | 2024 | β |
| Multi-Omics Integration Analysis Pinpoint Proteins Influencing Brain Structure and Function: Toward Drug Targets and Neuroimaging Biomarkers for Neuropsychiatric Disorders. | Wang Y et al. | β | 2024 | β |
| Network Analysis of Brain and Bone Tissue Transcripts Reveals Shared Molecular Mechanisms Underlying Alzheimer's Disease and Related Dementias and Osteoporosis. | Nagarajan A et al. | β | 2024 | β |
| Omnibus proteome-wide association study identifies 43 risk genes for Alzheimer disease dementia. | Hu T et al. | β | 2024 | β |
| Person-specific differences in ubiquitin-proteasome mediated proteostasis in human neurons. | Hsieh YC et al. | β | 2024 | β |
| Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of Ξ±-synuclein inclusions. | Lam I et al. | β | 2024 | β |
| Single-cell genomics and regulatory networks for 388 human brains. | Emani PS et al. | β | 2024 | β |
| SR-TWAS: leveraging multiple reference panels to improve transcriptome-wide association study power by ensemble machine learning. | Parrish RL et al. | β | 2024 | β |
| Structure-function coupling reveals the brain hierarchical structure dysfunction in Alzheimer's disease: A multicenter study. | Sun Y et al. | β | 2024 | β |
| Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress. | Goodman LD et al. | β | 2024 | β |
| The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing. | Liu Y et al. | β | 2024 | β |
| The MIND diet, brain transcriptomic alterations, and dementia. | Li J et al. | β | 2024 | β |
| The ROSMAP project: aging and neurodegenerative diseases through omic sciences. | PΓ©rez-GonzΓ‘lez AP et al. | β | 2024 | β |
| TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy. | Edwards GA et al. | β | 2024 | β |
| Transcriptional risk scores in Alzheimer's disease: From pathology to cognition. | Pyun JM et al. | β | 2024 | β |
| Translational bioinformatics and data science for biomarker discovery in mental health: an analytical review. | Bhuvaneshwar K et al. | β | 2024 | β |
| TREM2 variants that cause early dementia and increase Alzheimer's disease risk affect gene splicing. | Kiianitsa K et al. | β | 2024 | β |
| <u>M</u>onitoring drug <u>E</u>fficacy through <u>M</u>ulti-<u>O</u>mics <u>R</u>esearch initiative in <u>A</u>lzheimer's <u>D</u>isease (MEMORI-AD): A protocol for a multisite exploratory prospective cohort study on the drug response-related clinical, genetic, microbial and metabolomic signatures in Filipino patients with Alzheimer's disease. | Climacosa FMM et al. | β | 2024 | β |
| Unraveling the intercellular communication disruption and key pathways in Alzheimer's disease: an integrative study of single-nucleus transcriptomes and genetic association. | Liu A et al. | β | 2024 | β |
| Whole-genome sequencing study in Koreans identifies novel loci for Alzheimer's disease. | Kang M et al. | β | 2024 | β |
| Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease. | Xicota L et al. | β | 2024 | β |
| ZCCHC17 Modulates Neuronal RNA Splicing and Supports Cognitive Resilience in Alzheimer's Disease. | Bartosch AMW et al. | β | 2024 | β |
| 3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer's disease. | Lomoio S et al. | β | 2023 | β |
| Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles. | Chung J et al. | β | 2023 | β |
| A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice. | Barendrecht S et al. | β | 2023 | β |
| APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release. | Koutsodendris N et al. | β | 2023 | β |
| Batch Correction and Harmonization of -Omics Datasets with a Tunable Median Polish of Ratio. | Dammer EB et al. | β | 2023 | β |
| Benchmarking of deep neural networks for predicting personal gene expression from DNA sequence highlights shortcomings. | Sasse A et al. | β | 2023 | β |
| Bulk brain tissue cell-type deconvolution with bias correction for single-nuclei RNA sequencing data using DeTREM. | O'Neill NK et al. | β | 2023 | β |
| Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. | Yang HS et al. | β | 2023 | β |
| DeepGAMI: deep biologically guided auxiliary learning for multimodal integration and imputation to improve genotype-phenotype prediction. | Chandrashekar PB et al. | β | 2023 | β |
| Differential gene expression analysis based on linear mixed model corrects false positive inflation for studying quantitative traits. | Tang S et al. | β | 2023 | β |
| Effects of copy number variations on longevity in late-onset Alzheimer's disease patients: insights from a causality network analysis. | Hao Y et al. | β | 2023 | β |
| Evaluating genomic signatures of aging in brain tissue as it relates to Alzheimer's disease. | Lynch MT et al. | β | 2023 | β |
| Functional variants identify sex-specific genes and pathways in Alzheimer's Disease. | Bourquard T et al. | β | 2023 | β |
| Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins. | Oatman SR et al. | β | 2023 | β |
| Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer's disease through polygenic risk and RNA sequencing. | Crawford K et al. | β | 2023 | β |
| Identifying Aging and Alzheimer Disease-Associated Somatic Variations in Excitatory Neurons From the Human Frontal Cortex. | Zhang M et al. | β | 2023 | β |
| Identifying novel genes for amyotrophic lateral sclerosis by integrating human brain proteomes with genome-wide association data. | Gu XJ et al. | β | 2023 | β |
| INPP5D regulates inflammasome activation in human microglia. | Chou V et al. | β | 2023 | β |
| Integrative Co-methylation Network Analysis Identifies Novel DNA Methylation Signatures and Their Target Genes in Alzheimer's Disease. | Kim JP et al. | β | 2023 | β |
| Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. | Johnson EC et al. | β | 2023 | β |
| Investigation of early molecular alterations in tauopathy with generative adversarial networks. | Kim H et al. | β | 2023 | β |
| MODILM: towards better complex diseases classification using a novel multi-omics data integration learning model. | Zhong Y et al. | β | 2023 | β |
| Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer's disease. | Young-Pearse TL et al. | β | 2023 | β |
| Multicellular communities are perturbed in the aging human brain and Alzheimer's disease. | Cain A et al. | β | 2023 | β |
| Multi-omic integration via similarity network fusion to detect molecular subtypes of ageing. | Yang M et al. | β | 2023 | β |
| Multi-omics integration method based on attention deep learning network for biomedical data classification. | Gong P et al. | β | 2023 | β |
| Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer's disease at CPT1A locus. | Sarnowski C et al. | β | 2023 | β |
| Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning. | Neumann A et al. | β | 2023 | β |
| Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer's disease. | Siddiqui T et al. | β | 2023 | β |
| Neuronal actin cytoskeleton gain of function in the human brain. | Szigeti K et al. | β | 2023 | β |
| Overestimated prediction using polygenic prediction derived from summary statistics. | Park DK et al. | β | 2023 | β |
| Paired evaluation of machine-learning models characterizes effects of confounders and outliers. | Nariya MK et al. | β | 2023 | β |
| PAUSE: principled feature attribution for unsupervised gene expression analysis. | Janizek JD et al. | β | 2023 | β |
| Pooled analysis of frontal lobe transcriptomic data identifies key mitophagy gene changes in Alzheimer's disease brain. | Mei T et al. | β | 2023 | β |
| Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer's disease. | Merchant JP et al. | β | 2023 | β |
| Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. | Walker KA et al. | β | 2023 | β |
| Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. | Oliveros G et al. | β | 2023 | β |
| Sex differences in brain protein expression and disease. | Wingo AP et al. | β | 2023 | β |
| Sex specific molecular networks and key drivers of Alzheimer's disease. | Guo L et al. | β | 2023 | β |
| The molecular genetic landscape of human brain size variation. | Seidlitz J et al. | β | 2023 | β |
| The reverse transcriptase inhibitor 3TC protects against age-related cognitive dysfunction. | Wahl D et al. | β | 2023 | β |
| The role of mitochondrial genome abundance in Alzheimer's disease. | Harerimana NV et al. | β | 2023 | β |
| Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq. | Stokes T et al. | β | 2023 | β |
| TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation. | Moutinho M et al. | β | 2023 | β |
| A Final Frontier in Environment-Genome Interactions? Integrated, Multi-Omic Approaches to Predictions of Non-Communicable Disease Risk. | Noble AJ et al. | β | 2022 | β |
| Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease. | Thrush KL et al. | β | 2022 | β |
| Alzheimer's disease large-scale gene expression portrait identifies exercise as the top theoretical treatment. | Hill MA et al. | β | 2022 | β |
| A scalable Bayesian functional GWAS method accounting for multivariate quantitative functional annotations with applications for studying Alzheimer disease. | Chen J et al. | β | 2022 | β |
| Bioinformatics pipeline to guide late-onset Alzheimer's disease (LOAD) post-GWAS studies: Prioritizing transcription regulatory variants within LOAD-associated regions. | Lutz MW et al. | β | 2022 | β |
| Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. | Panitch R et al. | β | 2022 | β |
| Boosting mitochondrial health to counteract neurodegeneration. | Burtscher J et al. | β | 2022 | β |
| Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer's Disease. | Consens ME et al. | β | 2022 | β |
| Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders. | Bryois J et al. | β | 2022 | β |
| Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping. | Belloy ME et al. | β | 2022 | β |
| Characterizing the composition of iPSC derived cells from bulk transcriptomics data with CellMap. | Ouyang Z et al. | β | 2022 | β |
| Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. | Tcw J et al. | β | 2022 | β |
| Deep autoencoder for interpretable tissue-adaptive deconvolution and cell-type-specific gene analysis. | Chen Y et al. | β | 2022 | β |
| DeepPerVar: a multi-modal deep learning framework for functional interpretation of genetic variants in personal genome. | Wang Y et al. | β | 2022 | β |
| Deletion of Abi3/Gngt2 influences age-progressive amyloid Ξ² and tau pathologies in distinctive ways. | Ibanez KR et al. | β | 2022 | β |
| DIALOGUE maps multicellular programs in tissue from single-cell or spatial transcriptomics data. | Jerby-Arnon L et al. | β | 2022 | β |
| Discovery of Novel Drug Candidates for Alzheimer's Disease by Molecular Network Modeling. | Zhou J et al. | β | 2022 | β |
| Disease-specific interactome alterations via epichaperomics: the case for Alzheimer's disease. | Ginsberg SD et al. | β | 2022 | β |
| Epigenomic features related to microglia are associated with attenuated effect of APOE Ξ΅4 on Alzheimer's disease risk in humans. | Ma Y et al. | β | 2022 | β |
| Exposure to a real traffic environment impairs brain cognition in aged mice. | Xu C et al. | β | 2022 | β |
| FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. | Lee AJ et al. | β | 2022 | β |
| Genetic Evidence Supporting a Causal Role of Depression in Alzheimer's Disease. | Harerimana NV et al. | β | 2022 | β |
| Genome-wide association study and functional validation implicates JADE1 in tauopathy. | Farrell K et al. | β | 2022 | β |
| GEOMETRIC STRUCTURE GUIDED MODEL AND ALGORITHMS FOR COMPLETE DECONVOLUTION OF GENE EXPRESSION DATA. | Chen D et al. | β | 2022 | β |
| High Resolution Magic Angle Spinning Proton NMR Study of Alzheimer's Disease with Mouse Models. | FΓΌzesi MV et al. | β | 2022 | β |
| <i>APOE</i> Ξ΅4 and exercise interact in a sex-specific manner to modulate dementia risk factors. | Foley KE et al. | β | 2022 | β |
| Identification of novel proteins for lacunar stroke by integrating genome-wide association data and human brain proteomes. | Zhang C et al. | β | 2022 | β |
| Identification of risk genes for Alzheimer's disease by gene embedding. | Lagisetty Y et al. | β | 2022 | β |
| Identifying aging and Alzheimerβs disease associated somatic mutations in excitatory neurons from the human frontal cortex using whole genome sequencing and single cell RNA sequencing data | Zhang M et al. | β | 2022 | β |
| Identifying candidate genes and drug targets for Alzheimer's disease by an integrative network approach using genetic and brain region-specific proteomic data. | Liu A et al. | β | 2022 | β |
| Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood. | Deng YT et al. | β | 2022 | β |
| Identifying causal genes for stroke via integrating the proteome and transcriptome from brain and blood. | Wu BS et al. | β | 2022 | β |
| Integrating human brain proteomes with genome-wide association data implicates novel proteins in post-traumatic stress disorder. | Wingo TS et al. | β | 2022 | β |
| Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain. | Vialle RA et al. | β | 2022 | β |
| Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance. | Gao Y et al. | β | 2022 | β |
| Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease. | Horgusluoglu E et al. | β | 2022 | β |
| <i>pwrBRIDGE</i>: a user-friendly web application for power and sample size estimation in batch-confounded microarray studies with dependent samples. | Xia Q et al. | β | 2022 | β |
| Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level. | Johnson ECB et al. | β | 2022 | β |
| <i>Plcg2<sup>M28L</sup></i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in Mice. | Oblak AL et al. | β | 2022 | β |
| Medin co-aggregates with vascular amyloid-Ξ² in Alzheimer's disease. | Wagner J et al. | β | 2022 | β |
| Mining the transcriptome of target tissues of autoimmune and degenerative pancreatic Ξ²-cell and brain diseases to discover therapies. | Yi X et al. | β | 2022 | β |
| MSR1 and NEP Are Correlated with Alzheimer's Disease Amyloid Pathology and Apolipoprotein Alterations. | Miron J et al. | β | 2022 | β |
| Multiregion transcriptomic profiling of the primate brain reveals signatures of aging and the social environment. | Chiou KL et al. | β | 2022 | β |
| Network Tau spreading is vulnerable to the expression gradients of <i>APOE</i> and glutamatergic-related genes. | Montal V et al. | β | 2022 | β |
| Omnibus and robust deconvolution scheme for bulk RNA sequencing data integrating multiple single-cell reference sets and prior biological knowledge. | Chen C et al. | β | 2022 | β |
| PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease. | Tsai AP et al. | β | 2022 | β |
| Poly(A) RNA sequencing reveals age-related differences in the prefrontal cortex of dogs. | SΓ‘ndor S et al. | β | 2022 | β |
| Progranulin mutations in clinical and neuropathological Alzheimer's disease. | Vardarajan BN et al. | β | 2022 | β |
| Regio-Specific N-Glycome and N-Glycoproteome Map of the Elderly Human Brain With and Without Alzheimer's Disease. | Tena J et al. | β | 2022 | β |
| RNASE6 is a novel modifier of APOE-Ξ΅4 effects on cognition. | Seto M et al. | β | 2022 | β |
| SCADIE: simultaneous estimation of cell type proportions and cell type-specific gene expressions using SCAD-based iterative estimating procedure. | Tang D et al. | β | 2022 | β |
| Severe COVID-19 is associated with molecular signatures of aging in the human brain. | Mavrikaki M et al. | β | 2022 | β |
| Shared mechanisms across the major psychiatric and neurodegenerative diseases. | Wingo TS et al. | β | 2022 | β |
| Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer's disease. | Gupta C et al. | β | 2022 | β |
| swCAM: estimation of subtype-specific expressions in individual samples with unsupervised sample-wise deconvolution. | Chen L et al. | β | 2022 | β |
| The Key Factors Predicting Dementia in Individuals With Alzheimer's Disease-Type Pathology. | McCorkindale AN et al. | β | 2022 | β |
| The three-dimensional landscape of cortical chromatin accessibility in Alzheimer's disease. | Bendl J et al. | β | 2022 | β |
| Transcriptional landscape of human microglia implicates age, sex, and APOE-related immunometabolic pathway perturbations. | Patel T et al. | β | 2022 | β |
| Triplication of <i>Synaptojanin 1</i> in Alzheimer's Disease Pathology in Down Syndrome. | Hwang R et al. | β | 2022 | β |
| Truncated Tau caused by intron retention is enriched in Alzheimer's disease cortex and exhibits altered biochemical properties. | Ngian ZK et al. | β | 2022 | β |
| Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer's disease progression and heterogeneity. | Iturria-Medina Y et al. | β | 2022 | β |
| Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer's disease. | Traxler L et al. | β | 2022 | β |
| Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's disease. | Li F et al. | β | 2022 | β |
| Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer's disease. | Ming C et al. | β | 2022 | β |
| ADAS-viewer: web-based application for integrative analysis of multi-omics data in Alzheimer's disease. | Han S et al. | β | 2021 | β |
| ADeditome provides the genomic landscape of A-to-I RNA editing in Alzheimer's disease. | Wu S et al. | β | 2021 | β |
| A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with <i>NTNG1</i> and CNOT3. | Vattathil SM et al. | β | 2021 | β |
| Aging and Alzheimer's disease connection: Nuclear Tau and lamin A. | Gil L et al. | β | 2021 | β |
| Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of <i>TREM2</i> in Alzheimer's Disease by Splicing-Based Aggregation. | Han S et al. | β | 2021 | β |
| A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer's disease. | Huang Y et al. | β | 2021 | β |
| Atlas of RNA editing events affecting protein expression in aged and Alzheimer's disease human brain tissue. | Ma Y et al. | β | 2021 | β |
| BMI1 is associated with CS8F amyloid-Ξ² and rates of cognitive decline in Alzheimer's disease. | Kim JP et al. | β | 2021 | β |
| Brain proteome-wide association study implicates novel proteins in depression pathogenesis. | Wingo TS et al. | β | 2021 | β |
| Careful feature selection is key in classification of Alzheimer's disease patients based on whole-genome sequencing data. | Osipowicz M et al. | β | 2021 | β |
| Cascading epigenomic analysis for identifying disease genes from the regulatory landscape of GWAS variants. | Ng B et al. | β | 2021 | β |
| Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer's disease brain. | Klein HU et al. | β | 2021 | β |
| CoExp: A Web Tool for the Exploitation of Co-expression Networks. | GarcΓa-Ruiz S et al. | β | 2021 | β |
| Combinatorial analyses reveal cellular composition changes have different impacts on transcriptomic changes of cell type specific genes in Alzheimer's Disease. | Johnson TS et al. | β | 2021 | β |
| Comorbidity between Alzheimer's disease and major depression: a behavioural and transcriptomic characterization study in mice. | MartΓn-SΓ‘nchez A et al. | β | 2021 | β |
| DataRemix: a universal data transformation for optimal inference from gene expression datasets. | Mao W et al. | β | 2021 | β |
| Developmental synaptic regulator, TWEAK/Fn14 signaling, is a determinant of synaptic function in models of stroke and neurodegeneration. | Nagy D et al. | β | 2021 | β |
| Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1. | Li QS et al. | β | 2021 | β |
| Differential transcript usage unravels gene expression alterations in Alzheimer's disease human brains. | Marques-Coelho D et al. | β | 2021 | β |
| Dysregulation of the secretory pathway connects Alzheimer's disease genetics to aggregate formation. | Kuo CC et al. | β | 2021 | β |
| ECMarker: interpretable machine learning model identifies gene expression biomarkers predicting clinical outcomes and reveals molecular mechanisms of human disease in early stages. | Jin T et al. | β | 2021 | β |
| Effect of <i>APOE</i> alleles on the glial transcriptome in normal aging and Alzheimer's disease. | Serrano-Pozo A et al. | β | 2021 | β |
| Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration. | AlcalΓ -Vida R et al. | β | 2021 | β |
| Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer's disease. | He L et al. | β | 2021 | β |
| ExonSkipAD provides the functional genomic landscape of exon skipping events in Alzheimer's disease. | Yang M et al. | β | 2021 | β |
| From Reads to Insights: Integrative Pipelines for Biological Interpretation of ATAC-seq Data. | Cui Y et al. | β | 2021 | β |
| Genetic control of the human brain proteome. | Robins C et al. | β | 2021 | β |
| Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease. | Reddy JS et al. | β | 2021 | β |
| Harnessing the paradoxical phenotypes of APOE Ι2 and APOE Ι4 to identify genetic modifiers in Alzheimer's disease. | Kim YW et al. | β | 2021 | β |
| Hyper-graph based sparse canonical correlation analysis for the diagnosis of Alzheimer's disease from multi-dimensional genomic data. | Shao W et al. | β | 2021 | β |
| Identification of cell-type-specific marker genes from co-expression patterns in tissue samples. | Qiu Y et al. | β | 2021 | β |
| Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging. | Lee HY et al. | β | 2021 | β |
| IGF2R circular RNA hsa_circ_0131235 expression in the middle temporal cortex is associated with AD pathology. | BigarrΓ© IM et al. | β | 2021 | β |
| INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia. | Tsai AP et al. | β | 2021 | β |
| Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis. | Wingo AP et al. | β | 2021 | β |
| Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE Ξ΅2 protective effect in Alzheimer disease. | Panitch R et al. | β | 2021 | β |
| In vivo brain imaging of mitochondrial Ca<sup>2+</sup> in neurodegenerative diseases with multiphoton microscopy. | Calvo-Rodriguez M et al. | β | 2021 | β |
| KYNA/Ahr Signaling Suppresses Neural Stem Cell Plasticity and Neurogenesis in Adult Zebrafish Model of Alzheimer's Disease. | Siddiqui T et al. | β | 2021 | β |
| Mitochondria and Calcium in Alzheimer's Disease: From Cell Signaling to Neuronal Cell Death. | Calvo-Rodriguez M et al. | β | 2021 | β |
| Mitochondrial-nuclear cross-talk in the human brain is modulated by cell type and perturbed in neurodegenerative disease. | Fairbrother-Browne A et al. | β | 2021 | β |
| MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. | Wang T et al. | β | 2021 | β |
| Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets. | Neff RA et al. | β | 2021 | β |
| MOSTWAS: Multi-Omic Strategies for Transcriptome-Wide Association Studies. | Bhattacharya A et al. | β | 2021 | β |
| Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases. | Kapoor M et al. | β | 2021 | β |
| Multi-tissue neocortical transcriptome-wide association study implicates 8 genes across 6 genomic loci in Alzheimer's disease. | Gockley J et al. | β | 2021 | β |
| Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease. | Zalocusky KA et al. | β | 2021 | β |
| Non-coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women. | Blue EE et al. | β | 2021 | β |
| Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases. | La Cognata V et al. | β | 2021 | β |
| Parsing the Functional Impact of Noncoding Genetic Variants in the Brain Epigenome. | Powell SK et al. | β | 2021 | β |
| PathwayMultiomics: An R Package for Efficient Integrative Analysis of Multi-Omics Datasets With Matched or Un-matched Samples. | Odom GJ et al. | β | 2021 | β |
| Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models. | Gurdon B et al. | β | 2021 | β |
| Rare variants in the endocytic pathway are associated with Alzheimer's disease, its related phenotypes, and functional consequences. | Zhan L et al. | β | 2021 | β |
| scGRNom: a computational pipeline of integrative multi-omics analyses for predicting cell-type disease genes and regulatory networks. | Jin T et al. | β | 2021 | β |
| Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer's Disease. | Wang M et al. | β | 2021 | β |
| Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEΞ΅4 and Trem2*R47H. | Kotredes KP et al. | β | 2021 | β |
| Alzheimer's Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation. | Srinivasan K et al. | β | 2020 | β |
| A novel systems biology approach to evaluate mouse models of late-onset Alzheimer's disease. | Preuss C et al. | β | 2020 | β |
| Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. | Raghavan NS et al. | β | 2020 | β |
| Association of Early-Life Cognitive Enrichment With Alzheimer Disease Pathological Changes and Cognitive Decline. | Oveisgharan S et al. | β | 2020 | β |
| Bayesian Genome-wide TWAS Method to Leverage both cis- and trans-eQTL Information through Summary Statistics. | Luningham JM et al. | β | 2020 | β |
| Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks. | Klein HU et al. | β | 2020 | β |
| Ca<sup>2+</sup> Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer's Disease. | McDaid J et al. | β | 2020 | β |
| Characterizing the Causal Pathway for Genetic Variants Associated with Neurological Phenotypes Using Human Brain-Derived Proteome Data. | Kibinge NK et al. | β | 2020 | β |
| Clustering of Alzheimer's and Parkinson's disease based on genetic burden of shared molecular mechanisms. | Emon MA et al. | β | 2020 | β |
| Considerations for integrative multi-omic approaches to explore Alzheimer's disease mechanisms. | Ma Y et al. | β | 2020 | β |
| Deciphering cellular transcriptional alterations in Alzheimer's disease brains. | Wang X et al. | β | 2020 | β |
| EPIGENOMIC FEATURES RELATED TO MICROGLIA ARE ASSOCIATED WITH ATTENUATED EFFECT OF APOE Ξ΅4 ON ALZHEIMER'S DISEASE RISK IN HUMANS. | Ma Y et al. | β | 2020 | β |
| Erosion of Gene Co-expression Networks Reveal Deregulation of Immune System Processes in Late-Onset Alzheimer's Disease. | Malamon JS et al. | β | 2020 | β |
| Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease. | McQuade A et al. | β | 2020 | β |
| Genetics of Alzheimer's disease: where we are, and where we are going. | Bellenguez C et al. | β | 2020 | β |
| Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. | Yang HS et al. | β | 2020 | β |
| Identifying the molecular systems that influence cognitive resilience to Alzheimer's disease in genetically diverse mice. | Heuer SE et al. | β | 2020 | β |
| Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease. | Calvo-Rodriguez M et al. | β | 2020 | β |
| Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218. | Jurkiewicz M et al. | β | 2020 | β |
| Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer's disease. | Morabito S et al. | β | 2020 | β |
| Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression. | Wang Q et al. | β | 2020 | β |
| Meta-analysis of mouse transcriptomic studies supports a context-dependent astrocyte reaction in acute CNS injury versus neurodegeneration. | Das S et al. | β | 2020 | β |
| Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. | Wan YW et al. | β | 2020 | β |
| Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease. | Baloni P et al. | β | 2020 | β |
| Molecular estimation of neurodegeneration pseudotime in older brains. | Mukherjee S et al. | β | 2020 | β |
| Normal ageing of the brain: Histological and biological aspects. | Teissier T et al. | β | 2020 | β |
| Presymptomatic Increase of an Extracellular RNA in Blood Plasma Associates with the Development of Alzheimer's Disease. | Yan Z et al. | β | 2020 | β |
| Proteome-Scale Mapping of Perturbed Proteostasis in Living Cells. | Lam I et al. | β | 2020 | β |
| Pyk2 overexpression in postsynaptic neurons blocks amyloid Ξ²<sub>1-42</sub>-induced synaptotoxicity in microfluidic co-cultures. | Kilinc D et al. | β | 2020 | β |
| Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges. | Geerts H et al. | β | 2020 | β |
| Sex-dependent autosomal effects on clinical progression of Alzheimer's disease. | Fan CC et al. | β | 2020 | β |
| Systems modeling of white matter microstructural abnormalities in Alzheimer's disease. | Horgusluoglu-Moloch E et al. | β | 2020 | β |
| TargetDB: A target information aggregation tool and tractability predictor. | De Cesco S et al. | β | 2020 | β |
| The genetics of circulating BDNF: towards understanding the role of BDNF in brain structure and function in middle and old ages. | Li S et al. | β | 2020 | β |
| Transcriptomic Heterogeneity of Alzheimer's Disease Associated with Lipid Genetic Risk. | Miao X et al. | β | 2020 | β |
| Transcriptomic stratification of late-onset Alzheimer's cases reveals novel genetic modifiers of disease pathology. | Milind N et al. | β | 2020 | β |
| Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype. | Ma Y et al. | β | 2019 | β |
| A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. | Lanata CM et al. | β | 2019 | β |
| Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimer's Disease. | Brooks LRK et al. | β | 2019 | β |
| eQTLMAPT: Fast and Accurate eQTL Mediation Analysis With Efficient Permutation Testing Approaches. | Wang T et al. | β | 2019 | β |
| Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer's disease. | Pandey RS et al. | β | 2019 | β |
| Genetic risk for Alzheimer's dementia predicts motor deficits through multi-omic systems in older adults. | Tasaki S et al. | β | 2019 | β |
| Genetic variability in response to amyloid beta deposition influences Alzheimer's disease risk. | Salih DA et al. | β | 2019 | β |
| Informing disease modelling with brain-relevant functional genomic annotations. | Reynolds RH et al. | β | 2019 | β |
| Insulin and adipokine signaling and their cross-regulation in postmortem human brain. | Wang HY et al. | β | 2019 | β |
| Lost in translational biology: Understanding sex differences to inform studies of diseases of the nervous system. | Pearse RV et al. | β | 2019 | β |
| Microglia in Brain Development, Homeostasis, and Neurodegeneration. | Bohlen CJ et al. | β | 2019 | β |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. | International Multiple Sclerosis Genetics Consortium | β | 2019 | β |
| Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. | Felsky D et al. | β | 2019 | β |
| Nuclei multiplexing with barcoded antibodies for single-nucleus genomics. | Gaublomme JT et al. | β | 2019 | β |
| Somatic mosaicism of sex chromosomes in the blood and brain. | Graham EJ et al. | β | 2019 | β |
| Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease. | Hsieh YC et al. | β | 2019 | β |
| Deconstructing and targeting the genomic architecture of human neurodegeneration. | De Jager PL et al. | β | 2018 | β |